Literature DB >> 25863833

Lower Urinary Tract Symptoms and Risk of Bladder Cancer in Men: Results From the Health Professionals Follow-up Study.

Jiachen Zhou1, Karl T Kelsey2, Scott Smith3, Edward Giovannucci4, Dominique S Michaud5.   

Abstract

OBJECTIVE: To understand the association between lower urinary tract symptoms (LUTS) and risk of bladder cancer in a large cohort of men.
METHODS: Using data from the Health Professionals Follow-up Study, we examined risk of bladder cancer in relation to severity of LUTS among 30,183 men. During the follow-up period from 1996 until 2010, 476 newly diagnosed cases of bladder cancer occurred. The Cox proportional hazards regression was used to adjust for potential confounders.
RESULTS: Among men with severe LUTS, risk of bladder cancer was 64% higher (relative risk [RR], 1.64; 95% confidence interval [CI], 0.87-3.08) compared with men who reported no LUTS. Subjects with both voiding and storage dysfunction had a significantly higher risk of bladder cancer (RR, 1.60; 95% CI, 1.00-2.56). Among individual urinary symptoms, urinary hesitancy was strongly associated with bladder cancer; those who experienced urinary hesitancy at least 50% of the time had more than twice the risk of bladder cancer (RR, 2.21; 95% CI, 1.29-3.78).
CONCLUSION: Our findings suggest that LUTS, especially urinary hesitancy, are associated with the development of bladder cancer in men.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25863833      PMCID: PMC4479979          DOI: 10.1016/j.urology.2015.02.024

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  27 in total

1.  Prevalence of lower urinary tract symptoms in men aged 45-79 years: a population-based study of 40 000 Swedish men.

Authors:  Swen-Olof Andersson; Bahram Rashidkhani; Lars Karlberg; Alicja Wolk; Jan-Erik Johansson
Journal:  BJU Int       Date:  2004-08       Impact factor: 5.588

2.  Diagnostic values of detrusor wall thickness, postvoid residual urine, and prostate volume to evaluate lower urinary tract symptoms in men.

Authors:  Özlem Tokgöz; Hüsnü Tokgöz; Ilker Ünal; Umut Delibaş; Sema Yıldız; Nuray Voyvoda; Zuhal Erdem
Journal:  Diagn Interv Radiol       Date:  2011-12-19       Impact factor: 2.630

3.  Reexamination of total fluid intake and bladder cancer in the Health Professionals Follow-up Study Cohort.

Authors:  Jiachen Zhou; Scott Smith; Edward Giovannucci; Dominique S Michaud
Journal:  Am J Epidemiol       Date:  2012-02-21       Impact factor: 4.897

4.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Authors:  M J Barry; F J Fowler; M P O'Leary; R C Bruskewitz; H L Holtgrewe; W K Mebust; A T Cockett
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

5.  Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia.

Authors:  M J Barry; A T Cockett; H L Holtgrewe; J D McConnell; S A Sihelnik; H N Winfield
Journal:  J Urol       Date:  1993-08       Impact factor: 7.450

6.  Effectiveness of various mailing strategies among nonrespondents in a prospective cohort study.

Authors:  E B Rimm; M J Stampfer; G A Colditz; E Giovannucci; W C Willett
Journal:  Am J Epidemiol       Date:  1990-06       Impact factor: 4.897

7.  Postvoid residual urine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: pooled analysis of eleven controlled studies with alfuzosin.

Authors:  S A McNeill; T B Hargreave; C Geffriaud-Ricouard; J Santoni; C G Roehrborn
Journal:  Urology       Date:  2001-03       Impact factor: 2.649

8.  Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals.

Authors:  E B Rimm; E L Giovannucci; M J Stampfer; G A Colditz; L B Litin; W C Willett
Journal:  Am J Epidemiol       Date:  1992-05-15       Impact factor: 4.897

9.  Ultrasonic estimation of bladder weight as a measure of bladder hypertrophy in men with infravesical obstruction: a preliminary report.

Authors:  M Kojima; E Inui; A Ochiai; Y Naya; O Ukimura; H Watanabe
Journal:  Urology       Date:  1996-06       Impact factor: 2.649

10.  Reproducibility and validity of a semiquantitative food frequency questionnaire.

Authors:  W C Willett; L Sampson; M J Stampfer; B Rosner; C Bain; J Witschi; C H Hennekens; F E Speizer
Journal:  Am J Epidemiol       Date:  1985-07       Impact factor: 4.897

View more
  3 in total

Review 1.  Defining cisplatin eligibility in patients with muscle-invasive bladder cancer.

Authors:  Di Maria Jiang; Shilpa Gupta; Abhijat Kitchlu; Alejandro Meraz-Munoz; Scott A North; Nimira S Alimohamed; Normand Blais; Srikala S Sridhar
Journal:  Nat Rev Urol       Date:  2021-01-11       Impact factor: 14.432

2.  Moderate or severe LUTS is associated with increased recurrence of non - muscle - invasive urothelial carcinoma of the bladder.

Authors:  Austin Lunney; Allan Haynes; Pranav Sharma
Journal:  Int Braz J Urol       Date:  2019 Mar-Apr       Impact factor: 1.541

3.  A population-based cohort study examining the association of documented bladder diverticulum and bladder cancer risk in urology patients.

Authors:  Chu-Wen Fang; Vivian Chia-Rong Hsieh; Steven Kuan-Hua Huang; I-Ju Tsai; Chih-Hsin Muo; Shih-Chi Wu
Journal:  PLoS One       Date:  2019-10-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.